Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats

Keiko Matsumoto(Kagawa University), Toshio Ogihara(Osaka University), Ryuichi Morishita(The University of Osaka), Motokuni Aoki(Osaka City University), Naruya Tomita(M4 Engineering (United States)), Toshikazu Nakamura(The University of Osaka), Atsushi Moriguchi(The University of Osaka), Norio Komai(The University of Osaka), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Kunio Matsumoto(Kanazawa University)
Heart and Vessels
February 1, 2003
10.1007/s003800300003
Cited by 20

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588